Xiamen Nuokang Biotechnology Co., Ltd. is a leading international drug research and development company based on cabonhydrate biochemistry. Sugar chemical biology plays an important role in in vivo immunity. Nokang cooperates with Xiamen University and Michigan State University to establish a research and development center at home and abroad. The related technology is at the international first level. Nokang has achieved remarkable results in macrophage, NK cell new immunological checkpoint inhibitors, cell therapy based on chemical methods rather than genes, viral methods (CECT), and glycosylated breast cancer vaccines.


new medical research new medical research